The Brazilian Health Regulatory Agency (ANVISA) on Wednesday, August 18, recommended the Ministry of Health's National Immunization Plan (PNI) to consider a booster dose on an experimental basis for groups who have been administered two Coronavac doses, thereby prioritizing target groups such as immunocompromised patients and the elderly over 80.